标题
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
作者
关键词
-
出版物
Vaccines
Volume 10, Issue 11, Pages 1926
出版商
MDPI AG
发表日期
2022-11-15
DOI
10.3390/vaccines10111926
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Global impact of delta plus variant and vaccination
- (2022) Vivek P Chavda et al. Expert Review of Vaccines
- A global picture: therapeutic perspectives for COVID-19
- (2022) Vivek P Chavda et al. Immunotherapy
- The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant
- (2022) Dandan Tian et al. JOURNAL OF MEDICAL VIROLOGY
- Omicron Variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?
- (2022) Vivek P Chavda et al. MATURITAS
- Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
- (2022) Kang Wang et al. NATURE
- mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
- (2022) Henning Gruell et al. NATURE MEDICINE
- Neutralizing antibodies against the SARS-CoV-2 Omicron variant following homologous and heterologous CoronaVac or BNT162b2 vaccination
- (2022) Samuel M. S. Cheng et al. NATURE MEDICINE
- Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
- (2022) Emi Takashita et al. NEW ENGLAND JOURNAL OF MEDICINE
- Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant
- (2022) Baisheng Li et al. Nature Communications
- Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
- (2022) Xun Wang et al. Emerging Microbes & Infections
- Severe Acute Respiratory Syndrome Type 2‐Causing Coronavirus: Variants and Preventive Strategies
- (2022) Mehmet Onur Aydogdu et al. Advanced Science
- Identification of SARS-CoV-2 Variants and Their Clinical Significance in Hefei, China
- (2022) Xiao-wen Cheng et al. Frontiers in Medicine
- Therapeutic monoclonal antibodies for COVID-19 management: an update
- (2022) Vivek P Chavda et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Why Does the Omicron Variant Largely Spare Olfactory Function? Implications for the Pathogenesis of Anosmia in Coronavirus Disease 2019
- (2022) Rafal Butowt et al. JOURNAL OF INFECTIOUS DISEASES
- SARS‐CoV‐2 variants and vulnerability at the global level
- (2022) Vivek P. Chavda et al. JOURNAL OF MEDICAL VIROLOGY
- Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial
- (2022) Igor Smolenov et al. LANCET INFECTIOUS DISEASES
- Sustainability of surveillance systems for SARS-CoV-2
- (2022) Cornelia Adlhoch et al. LANCET INFECTIOUS DISEASES
- Humoral response to the BBIBP-CorV vaccine over time in healthcare workers with or without exposure to SARS-CoV-2
- (2022) María Noel Badano et al. MOLECULAR IMMUNOLOGY
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial
- (2022) Yu Cao et al. Science China-Life Sciences
- Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam
- (2022) Anh Duc Dang et al. VACCINE
- Effects of Casirivimab/Imdevimab Monoclonal Antibody Treatment among Vaccinated Patients Infected by SARS-CoV-2 Delta Variant
- (2022) Gaetano Cicchitto et al. Viruses-Basel
- Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena
- (2022) Vivek P. Chavda et al. Viruses-Basel
- Covid-19: What do we know about the delta omicron recombinant variant?
- (2022) Elisabeth Mahase BMJ-British Medical Journal
- Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
- (2022) Yang Liu et al. Cell Reports
- Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
- (2022) Vivek P. Chavda et al. Vaccines
- Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
- (2022) Hao Zhou et al. CLINICAL MICROBIOLOGY REVIEWS
- COVID-19 vaccine design and vaccination strategy for emerging variants
- (2022) Vivek P. Chavda et al. Expert Review of Vaccines
- Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial
- (2022) Suvimol Niyomnaitham et al. JOURNAL OF INFECTION
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial
- (2022) Xuan-Yi Wang et al. Emerging Microbes & Infections
- Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial
- (2022) Rolando Ochoa-Azze et al. Lancet Respiratory Medicine
- An Antibody from Single Human V H -rearranging Mouse Neutralizes All SARS-CoV-2 Variants Through BA.5 by Inhibiting Membrane Fusion
- (2022) Sai Luo et al. Science Immunology
- Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge
- (2022) David T. Huang et al. JAMA Network Open
- Evasion of neutralising antibodies by omicron sublineage BA.2.75
- (2022) Daniel J Sheward et al. LANCET INFECTIOUS DISEASES
- Recent review of COVID-19 management: diagnosis, treatment and vaccination
- (2022) Vivek P. Chavda et al. Pharmacological Reports
- A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19
- (2022) Chih-Jung Chen et al. Nature Communications
- Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
- (2022) Vivek P. Chavda et al. Frontiers in Immunology
- Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
- (2021) Bryan A. Johnson et al. NATURE
- Human SARS CoV ‐2 spike protein mutations
- (2021) Lalitha Guruprasad PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- The Variant Gambit: COVID’s Next Move
- (2021) Jessica A. Plante et al. Cell Host & Microbe
- COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients
- (2021) Jennifer A. Belsky et al. JOURNAL OF INFECTION
- New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
- (2021) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine Breakthrough Infections with SARS-CoV-2 Variants
- (2021) Ezgi Hacisuleyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes
- (2021) Irwin Jungreis et al. Nature Communications
- SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression.
- (2021) Artem Nemudryi et al. Cell Reports
- Comparison of saliva with healthcare workers- and patient-collected swabs in the diagnosis of COVID-19 in a large cohort
- (2021) Mitnala Sasikala et al. BMC INFECTIOUS DISEASES
- Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
- (2021) Vivek P. Chavda et al. DRUG DISCOVERY TODAY
- Impact of the Delta variant on vaccine efficacy and response strategies
- (2021) Lianlian Bian et al. Expert Review of Vaccines
- Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case
- (2021) Bradley A Connor et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples
- (2021) Timothy A. Bates et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mechanisms of Antiviral Immune Evasion of SARS-CoV-2
- (2021) Daniel K Beyer et al. JOURNAL OF MOLECULAR BIOLOGY
- Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19-recovered vaccinated individuals
- (2021) Gajanan N Sapkal et al. JOURNAL OF TRAVEL MEDICINE
- Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants
- (2021) Angela Choi et al. JOURNAL OF VIROLOGY
- Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
- (2021) Emma C Wall et al. LANCET
- AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
- (2021) Emma C Wall et al. LANCET
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
- (2021) Angela Choi et al. NATURE MEDICINE
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
- (2021) Dan H. Barouch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
- (2021) Meagan P. O’Brien et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Variants in Patients with Immunosuppression
- (2021) Lawrence Corey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delta variant triggers new phase in the pandemic
- (2021) Kai Kupferschmidt et al. SCIENCE
- Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
- (2021) Lennox Chitsike et al. Virology Journal
- SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
- (2021) Jiří Zahradník et al. Nature Microbiology
- A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals
- (2021) Vivek P Chavda et al. Vaccines
- Effect of SARS-CoV-2 Mutations on the Efficacy of Antibody Therapy and Response to Vaccines
- (2021) Ahmed Yaqinuddin et al. Vaccines
- Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada
- (2021) David N. Fisman et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- DNA vaccines for SARS-CoV-2: toward third-generation vaccination era
- (2021) Vivek P Chavda et al. Expert Review of Vaccines
- Omicron Has Reached the US—Here’s What Infectious Disease Experts Know About the Variant
- (2021) Jennifer Abbasi JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses
- (2021) Saathvik R. Kannan et al. JOURNAL OF AUTOIMMUNITY
- N501Y and K417N Mutations in the Spike Protein of SARS-CoV-2 Alter the Interactions with Both hACE2 and Human-Derived Antibody: A Free Energy of Perturbation Retrospective Study
- (2021) Filip Fratev Journal of Chemical Information and Modeling
- Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge
- (2021) Dennis M. Bierle et al. JOURNAL OF CLINICAL VIROLOGY
- Omicron: Call for updated vaccines
- (2021) Xingguang Li JOURNAL OF MEDICAL VIROLOGY
- The global epidemic of SARS‐CoV‐2 variants and their mutational immune escape
- (2021) Dandan Tian et al. JOURNAL OF MEDICAL VIROLOGY
- Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein
- (2021) Suresh Kumar et al. JOURNAL OF MEDICAL VIROLOGY
- Predicting Mutational Effects on Receptor Binding of the Spike Protein of SARS-CoV-2 Variants
- (2021) Chen Bai et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
- (2021) Salim S Abdool Karim et al. LANCET
- Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
- (2021) Wanwisa Dejnirattisai et al. LANCET
- Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
- (2021) Alasdair P S Munro et al. LANCET
- CoronaVac induces lower neutralising activity against variants of concern than natural infection
- (2021) Vimvara Vacharathit et al. LANCET INFECTIOUS DISEASES
- Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
- (2021) Akatsuki Saito et al. NATURE
- Booster Doses and Prioritizing Lives Saved
- (2021) Minal K. Patel NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea
- (2021) Moon Seong Baek et al. PLoS One
- Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium
- (2021) Rajaneesh K. Gupta et al. PLoS One
- A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice
- (2021) David R. Martinez et al. Science Translational Medicine
- Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity
- (2021) Shang Yu Gong et al. VIROLOGY
- Identification of genotypic variants and its proteomic mutations of Brazilian SARS-CoV-2 isolates
- (2021) Ragothaman Prathiviraj et al. VIRUS RESEARCH
- The emergence of new SARS-CoV-2 variant (Omicron) and increasing calls for COVID-19 vaccine boosters-The debate continues
- (2021) Naushad Ahmad Khan et al. Travel Medicine and Infectious Disease
- The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
- (2021) Dandan Tian et al. Frontiers in Immunology
- Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
- (2021) Liyana Ahmad Frontiers in Immunology
- Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants
- (2021) Rüdiger Groß et al. EBioMedicine
- Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses
- (2020) Tuan M. Nguyen et al. CELL RESEARCH
- The outbreak of COVID-19
- (2020) Yi-Chi Wu et al. Journal of the Chinese Medical Association
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy
- (2020) Domenico Benvenuto et al. JOURNAL OF INFECTION
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
- (2020) Xiangyang Chi et al. SCIENCE
- Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
- (2020) Ching-Lin Hsieh et al. SCIENCE
- Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
- (2020) Vibhuti Kumar Shah et al. Frontiers in Immunology
- SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
- (2020) Lizhou Zhang et al. Nature Communications
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now